期刊文献+

胃肠道间质瘤CD117 CD34和Ki-67的表达与临床病理因素的相关性 被引量:2

Expression of CD117 CD34 and Ki-67 in Gastrointestinal Stromal Tumors and its Correlation with Clinicopathological Factors of GISTs
下载PDF
导出
摘要 目的:探讨胃肠道间质瘤(gastrointestinal stromal tumor,GIST)CD117、CD34和Ki-67的表达率和表达强度及其与临床病理相关因素和危险度的关系。方法:应用免疫组化S-P法检测57例GISTs的CD117、CD34和Ki-67的表达情况,并分析上述免疫组化指标在表达率方面与临床病理相关因素(性别、年龄、发生部位)的关系。并对这些病例进行危险度分级,进一步探讨上述免疫组化指标在表达程度方面与危险度之间的关系。结果:CD117和CD34的阳性表达率分别为84.2%、71.9%。CD34阳性表达率在不同性别、年龄组之间没有显著性差异,但在肠道外GISTs阳性表达率高于肠道(P<0.05)。CD117的阳性表达强度和Ki-67增殖指数在不同的危险度之间存在显著性差异(P<0.05)。且CD117阳性表达强度、Ki-67增殖指数和危险度的分级呈正相关。结论:CD117和CD34在GIST中均呈高表达率,但肠道GIST诊断时,CD117的阳性表达更准确、可靠。CD117表达强度和Ki-67增殖指数和危险度的分级呈正相关,可能是判断GIST危险度的可靠指标之一。 Objective:To investigate the expression rates and the expression levels of CD117、CD34 and Ki-67 in gastrointestinal stromal tumors(GISTs)and its relationship with the clinicopathological features and risk rank of G1STs.Methods:To detect the expression rates and the expression levels of CD117、CD34 and Ki-67 in 57 cases of GISTs by immunohistochemical S-P,and to analysis the relations of immunohistochemistry of the above indicators and related clinicopathological factors(gender,age,location).To further explore the relationship of the rank of risk and immunohistochemistry of the above indicators.Results:The positive expression rates of CD117 and CD34 were 84.2% and 71.9%.There had no significant difference in the different gender and age group on the positive expression rates of CD34.The positive expression rates of CD34 in parenteral is higher than that of intestinal.The positive Expression intensity of CD117 and the proliferation index of Ki-67 is significant different in the different rank of risk(P〈0.05).The positive expression intensity of CD117 and the proliferation index of Ki-67 was positively correlated with risk classification.Conclusion:CD117 and CD34 in GIST was in high expression levels,and had a certain significance in the diagnosis of GIST.And the expression intensity of CD117 and the proliferation index of Ki-67 was positively correlated with risk classification.They may be one of the.reliable indicators in judging the risk of GIST.
作者 尚瑞刚 闫军
机构地区 山西医科大学
出处 《长治医学院学报》 2008年第3期168-171,共4页 Journal of Changzhi Medical College
关键词 胃肠道间质瘤 CD117 CD34 KI-67 危险度 Gastrointestinal Stromal Tumor CD117 CD34 Ki-67 Risk
  • 相关文献

参考文献11

  • 1Kindblom LG, Remotti HE, Aldenborg F, et al . Gastrointestinal stromal tumors show phenotypic characteristics of the intestinal cells of Cajal[J] .Am J Pathol, 1998,152(5) : 1 259 - 1 269.
  • 2Hirota S,Isozaki K,Moriiyama Y, et al .Gain - of- functionmutation of c - kit in human gastrointestinal stromal tumor [ J ]. Science, 1998,279(5350) :577 - 580.
  • 3刘晓红,马大烈,吴丽莉,白辰光,胡宏杰.原癌基因c-kit在胃肠道间质瘤中的表达及其临床意义[J].中华外科杂志,2002,40(4):277-279. 被引量:29
  • 4冯菲,马大烈,刘伟强,白辰光,杨建辉.巢蛋白(Nestin)在胃肠道间质瘤组织中的表达及其临床意义[J].实用癌症杂志,2004,19(1):24-26. 被引量:16
  • 5Can B,Sokmensuer C. clinicopathologic features, cellular dif ferentiation, PCNA and P53 expressions in gastrointestinal stromal tumors [ J ]. Hepatogastroenterology, 2003,50 (Suppl2) : ccx1iii - ccx1vi.
  • 6Logrono R,Jones DV,Faruqi S, et al .Recent advances in cellbiology, diagnosis and therapy of gastrointestinal stroma tumor(GIST)[J ]. Cancer Biol Ther,2004,3(3):251 -258.
  • 7Wasag B,Debiec- Rychter M, Pauwels P, et al . Diferential expression of KIT/PDGFRA mutant isoforms in epithelioid andmixed variants of gastrointestinal stromal tumors depends predominantly on the tumor site[J] .Mod Pathol,2004,17(8) :889 - 894.
  • 8Fujimoto Y, Nakanishi Y, Yoshimura K, et al . Clinieopathologic study of primary malignant gastrointestinal stromal tumorof the stomach, with special reference to prognostic factors : analysis of results in 140 surgically resected patients[J] .Gastric Cancer,2003,6( 1 ) :39 - 48.
  • 9孔庆兖,卢敏华,陈菊荣,朱从敏.109例胃肠间质瘤临床病理研究[J].徐州医学院学报,2000,20(5):354-357. 被引量:8
  • 10Wang L,Vargas H,French SW.Cefluar origin of gastrointestinal stromal tumors : a study of 27 cases [ J ]. Arch Pathol LabMed, 2000,124 (10):1 471-1 475.

二级参考文献20

  • 1Hirota S, Isozaki K, Moriiyama Y, et al. Gain-of-function mutation of C-kit in human gastrointestinal stromal tumors[J]. Science, 1998,279(23) : 577.
  • 2Nakahara M, Isozaki K, Hirota S, et al. A novel gain-offunction mutation of C-kit gene in gastrointestinal stroreal tumors[J ]. Gastroenterology, 1998,115(5) : 1090.
  • 3Lewin K J, Riddell RH, Weinstein WM. Gastrointestinal pathology and its clinical implications[M]. 1 st ed. New York : Igaku-shoin, 1992 : 284.
  • 4Mazur M,Clark HB. Gastric stromal tumors:Reappraisal of histogenesis[J]. Am J Surg Pathol, 1983,7(6) :507.
  • 5grnst SI, Hubbs Ag,Przygodzki RM,et al. Kit mutation protends poor prognosis in gastrointestinal stromal/smooth muscle tumors [J]. Lab Invest, 1998, 78 (12) :1633.
  • 6Lendahl U, Zimmerman LB, McKay RDG. CNS stem cell express a new class of intermediate filament protein [J]. Cell, 1990,60(4): 585.
  • 7Tsujimura T, Makiishi-Shimobayashi C, Lundkvist J, et al. Expression of the intermediate filament nestin in gastrointestinal stromal tumors and interstitial cells of Cajal [J]. Am J Pathol,2001,158(3) :817.
  • 8Maeda H, Yamagata A, Nishikawa S, et al. Requirement of c-kit for development of intestinal pacemaker system[J]. Development, 1992,116 (2) : 369.
  • 9Hirota S. Gastrointestinal stromal tumors: their origin and cause[J]. Int J Oncol, 2001,6( 1 ) : 1.
  • 10Robinson TL, Sircar K, Hewlett BR, et al. Gastrointestinal stromal tumors may originate from a subset of CD34-positive interstitial cells of Cajal[J]. Am J Pathol, 2000,156(4) : 1157.

共引文献42

同被引文献18

引证文献2

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部